Search

Author/Creator Ronga, Philippe

1. Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing. Issue 2 (20th January 2017)

Authors:
Schmiegel, Wolff; Scott, Rodney J.; Dooley, Susan; Lewis, Wendy; Meldrum, Cliff J.; Pockney, Peter; Draganic, Brian; Smith, Steve; Hewitt, Chelsee; Philimore, Hazel; Lucas, Amanda; Shi, Elva; Namdarian, Kateh; Chan, Timmy; Acosta, Danilo; Ping‐Chang, Su; Tannapfel, Andrea; Reinacher‐Schick, Anke;...
Journal:
Molecular oncology
Issue:
Volume 11:Issue 2(2017)
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study. (3rd May 2020)

Authors:
Stintzing, Sebastian; van Oostrum, Ilse; Pescott, Chris P.; Ronga, Philippe; Heeg, Bart; Heinemann, Volker
Journal:
Journal of medical economics
Issue:
Volume 23:Number 5(2020)
Page Start:
448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search